missing translation for 'onlineSavingsMsg'
Learn More

Perilipin-2/ADFP Mouse anti-Human, Clone: rADFP/1493, Novus Biologicals™

Mouse Monoclonal Antibody

499.00€

Specifications

Antigen Perilipin-2/ADFP
Clone rADFP/1493
Concentration 0.2 mg/mL
Dilution ELISA, Immunohistochemistry-Paraffin 1 to 2 μg/mL
Applications ELISA, Immunohistochemistry (Paraffin)
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18641438
View Documents
Novus Biologicals
NBP3-07882-100ug
100 μg
499.00€
100µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Perilipin-2/ADFP Monoclonal specifically detects Perilipin-2/ADFP in Human samples. It is validated for ELISA, Immunohistochemistry-Paraffin.
Specifications

Specifications

Perilipin-2/ADFP
0.2 mg/mL
ELISA, Immunohistochemistry (Paraffin)
Unconjugated
Mouse
Cancer, Hypoxia, Lipid and Metabolism, Lipid Droplets, Signal Transduction
10 mM PBS with 0.05% BSA
123
IgG1 κ
Protein A or G purified
rADFP/1493
ELISA, Immunohistochemistry-Paraffin 1 to 2 μg/mL
Monoclonal
Purified
RUO
Human
ADFP, Adipophilin, Adipose differentiation-related proteinadipophilin, ADRP, MGC10598, perilipin 2, perilipin-2
Recombinant fragment (around aa 249-376) of human Perilipin-2/ADFP protein (exact sequence is proprietary)
Primary
Store at 4°C.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.